Explore more publications!
Cincinnati Wellness Review
Submit Press Release

Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 15, 2025

Polaris Vein & Aesthetics Invites Community to Prioritize Self-Care During September’s Self-Care Awareness Month
September 15, 2025

Polaris Vein & Aesthetics Invites Community to Prioritize Self-Care During September’s Self-Care Awareness Month

Indeterminate EIN Presswire
ProbateCourtBond.com Announces Inaugural Building Bonds™ Scholarship Winners
September 15, 2025

ProbateCourtBond.com Announces Inaugural Building Bonds™ Scholarship Winners

Indeterminate EIN Presswire
VitalHub Announces Change of Auditor
September 15, 2025

VitalHub Announces Change of Auditor

Indeterminate GlobeNewswire
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
September 15, 2025

Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne

Indeterminate GlobeNewswire
Supporting Heart Health in Our Communities
September 15, 2025

Supporting Heart Health in Our Communities

Indeterminate GlobeNewswire
Parexel and Paradigm Health Partner to Expand Access and Efficiency in Clinical Trials
September 15, 2025

Parexel and Paradigm Health Partner to Expand Access and Efficiency in Clinical Trials

Indeterminate GlobeNewswire
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
September 15, 2025

Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
September 15, 2025

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Indeterminate GlobeNewswire
Nyxoah Entame une Procédure Judiciaire pour Violation de Brevets Contre Inspire Medical Systems, Inc.
September 15, 2025

Nyxoah Entame une Procédure Judiciaire pour Violation de Brevets Contre Inspire Medical Systems, Inc.

Indeterminate GlobeNewswire
UPDATE – Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration
September 15, 2025

UPDATE – Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration

Indeterminate GlobeNewswire
Women’s Health Collective Canada Launches Vital Talks National Seminar Series with the Support of Vichy Laboratoires
September 15, 2025

Women’s Health Collective Canada Launches Vital Talks National Seminar Series with the Support of Vichy Laboratoires

Indeterminate GlobeNewswire
L’Association canadienne pour l’équité en santé des femmes (ACESF) lance la série de séminaires nationaux Conversations vitales avec le soutien de Vichy Laboratoires
September 15, 2025

L’Association canadienne pour l’équité en santé des femmes (ACESF) lance la série de séminaires nationaux Conversations vitales avec le soutien de Vichy Laboratoires

Indeterminate GlobeNewswire
AdCare Rhode Island Appoints New Executive Director as Facility Expansion Nears Completion to Serve More People Struggling with Addiction
September 15, 2025

AdCare Rhode Island Appoints New Executive Director as Facility Expansion Nears Completion to Serve More People Struggling with Addiction

Indeterminate GlobeNewswire
Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
September 15, 2025

Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025

Indeterminate GlobeNewswire
Immune Thrombocytopenic Purpura Market to Grow at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight
September 15, 2025

Immune Thrombocytopenic Purpura Market to Grow at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight

Indeterminate GlobeNewswire
National Association of Specialty Pharmacy Congratulates Industry Award Winners at its Record-Breaking 2025 Annual Meeting & Expo
September 15, 2025

National Association of Specialty Pharmacy Congratulates Industry Award Winners at its Record-Breaking 2025 Annual Meeting & Expo

Indeterminate GlobeNewswire
Press release: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
September 15, 2025

Press release: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM

Indeterminate GlobeNewswire
Guerbet : Adjustment of 2025 full-year financial targets
September 15, 2025

Guerbet : Adjustment of 2025 full-year financial targets

Indeterminate GlobeNewswire
Guerbet : Ajustement des objectifs financiers annuels 2025
September 15, 2025

Guerbet : Ajustement des objectifs financiers annuels 2025

Indeterminate GlobeNewswire
Organic & Natural Health Leads First-Ever My Health Alliance Lobby Day on Capitol Hill
September 15, 2025

Organic & Natural Health Leads First-Ever My Health Alliance Lobby Day on Capitol Hill

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions